BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/7/2016 11:32:00 AM | Browse: 1194 | Download: 1717
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 21118
Country/Territory Lebanon
Received
2015-06-30 15:31
Peer-Review Started
2015-07-02 09:01
To Make the First Decision
2015-09-16 09:12
Return for Revision
2015-09-22 16:44
Revised
2015-11-09 19:15
Second Decision
2015-12-10 17:59
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2015-12-21 11:10
Articles in Press
2015-12-21 11:10
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2016-02-26 09:35
Publish the Manuscript Online
2016-03-07 11:32
ISSN 1948-5204 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/ licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Minireviews
Article Title Is metastatic pancreatic cancer an untargetablemalignancy?
Manuscript Source Invited Manuscript
All Author List Hampig Raphael Kourie, Joseph Gharios, Fadi Elkarak, Joelle Antoun and Marwan Ghosn
Funding Agency and Grant Number
Corresponding Author Marwan Ghosn, MD, Department of Oncology, Faculty of Medicine, Saint Joseph University, Monot St, PO Box 166830, Beirut, Lebanon. marwanghonmd@yahoo.com
Key Words Pancreatic cancer; Tumor suppressor genes; Targeted therapies; Immunotherapy; Epigenetics
Core Tip This paper will report on the most recent updates in the treatment of metastatic pancreatic cancer (MPC). We present the major causes rendering MPC an untargetable malignancy and we focus on the new therapeutic modalities based on targeted therapies in MPC.
Publish Date 2016-03-07 11:32
Citation Kourie HR, Gharios J, Elkarak F, Antoun J, Ghosn M. Is metastatic pancreatic cancer an untargetable malignancy? World J Gastrointest Oncol 2016; 8(3): 297-304
URL http://www.wjgnet. com/1948-5204/full/v8/i3/297.htm
DOI http://dx.doi.org/10.4251/wjgo.v8.i3.297
Full Article (PDF) WJGO-8-297.pdf
Full Article (Word) WJGO-8-297.doc
Manuscript File 21118-Review.docx
Answering Reviewers 21118-Answering reviewers.pdf
Audio Core Tip 21118-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 21118-Conflict-of-interest statement.pdf
Copyright License Agreement 21118-Copyright assignment.pdf
Peer-review Report 21118-Peer-review(s).pdf
Scientific Misconduct Check 21118-Scientific misconduct check.pdf
Scientific Editor Work List 21118-Scientific editor work list.pdf